Skip to main content

13.03.2019 | Glioblastom | International Research Highlight | Onlineartikel

International Research Highlight

CNS Cancer: CSF DNA provides a snapshot of the glioma genome

David Killock
Genetic profiling is increasingly being used for disease classification and treatment allocation in patients with diffuse gliomas, which include glioblastoma and lower-grade gliomas. Owing to the location of these tumours, tissue sampling is challenging, particularly repeat sampling aimed at capturing disease evolution following therapy. Liquid biopsy sampling provides new opportunities in this regard, but the scope for blood-based detection of DNA derived from central nervous system (CNS) cancers might be limited by the blood–brain barrier. Now, a study reported in Nature highlights the promise of genetic profiling of gliomas via liquid biopsy of cerebrospinal fluid (CSF).

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weiterführende Themen

Passend zum Thema

Dossier zum Deutschen Krebskongress

Was sind die Highlights auf dem Deutschen Krebskongress 2020 in Berlin? Wissenswertes zum Kongress haben wir in diesem Dossier für Sie gesammelt: Hinweise auf spannende Veranstaltungen, Kongressberichte und Experteninterviews.